1. Alberta Diabetes Atlas 2009 and 2011

2. ADSS SC Terms of Reference 1. Advise on Table of Contents and Working Groups for the Alberta Diabetes Atlas 2. Advise on format and functionality of ADSS website 3. Advise on communication strategy for ADSS 4. When feasible, act as a contributor to relevant sections/chapters of the Atlas 5. Advise on formulation of evaluation plan for ADSS

3. 2009 Atlas Table of Contents 2009 Chapter 1: Background and Methods Chapter 2: Epidemiological Trends Trends over time, across age and by region Chapter 3: Diabetes and HC Utilization Physician Visits, ER, Hospitalization Cost component: drug costs/system and patient costs for years 65+ (Blue Cross)

4. 2009 Atlas Table of Contents 2009 Chapter 4: Diabetes and Cardiovascular Disease  Acute Coronary Syndrome (Acute MI, unstable angina, PCI and CABG)  Heart Failure  Stroke  Michael Hill, neurologist UC  Hypertension (new PHAC/CCDSS case def’n)  Hude Quan

5. 2009 Atlas Table of Contents 2009 Chapter 5: Diabetes and Lower Limb Amputation  Add: Diabetes and Foot Disease as a separate chapter?  Brent Haverstock- Division of Podiatric Surgery, UC Chapter 6: Diabetes and Kidney Disease  Dialysis and Transplantation Chapter 7: Diabetes and Eye Disease  Retinal photocoagulation, Vitrectomy, Glaucoma and Cataract Surgery

6. 2009 Atlas Table of Contents 2009 Chapter 8: Diabetes and Mental Health  Affective disorders  Anxiety disorders  Non-organic and organic psychoses  Substance Abuse disorders  Eating disorders  Scott Patten- Psychiatrist in Calgary Chapter 9: Diabetes and First Nations people

7. 2009 Atlas Table of Contents 2009 Chapter 10: Diabetes in the Under 20 Year Olds  Same case definition as adult population  Require information about case ascertainment (hospital vs. physician) Chapter 11: Diabetes and Pregnancy  FOMD Team ( Padma Kaul, Eddie Ryan, Connie Chick, JAJ )  PHAC/CCDSS def’n  Could consider different approaches.

8. 2009 Atlas Working Groups Chapter 1: Background and Methods Chapter 2: Epidemiological Trends Jeff Johnson and Stephanie Vermeulen Chapter 3: Diabetes and HC Utilization Jeff Johnson, Doreen Rabi, Alun Edwards, Stephanie Vermeulen

9. 2009 Atlas Working Groups Chapter 4: Diabetes and Cardiovascular Disease  Acute Coronary Syndrome Michelle Graham, Colleen Norris, Sumit Majumdar, Jeff Johnson  Heart Failure Finlay McAlister, Dean Eurich  Stroke Scot Simpson, ?? Michael Hill  Hypertension ?? Hude Quan, Larry Svenson

10. 2009 Atlas Working Groups Chapter 5: Diabetes and Lower Limb Amputations (??and Foot Disease)  Peter Senior, Sean McMurtry, Ross Tsuyuki, Brent Haverstock Chapter 6: Diabetes and Kidney Disease  Scott Klarenbach, Marcello Tonelli, Brenda Hemmelgarn, Kailash Jindal Chapter 7: Diabetes and Eye Disease  Matthew Tennant, Christopher Rudnisky, Jeff Johnson

11. 2009 Atlas Working Groups Chapter 8: Diabetes and Mental Health Disorders  Scott Patten, Larry Svenson, Lauren Brown Chapter 9: Diabetes and First Nations People  Brenda Hemmelgarn, Ellen Toth, Malcolm King, Lynden Crowshoe, Kelli Ralph-Campbell Chapter 10: Diabetes in the Under 20 Year Old Population  Bob Couch, Seth Marks, Daniele Pacaud, Jeff Johnson Chapter 11: Diabetes and Pregnancy  Padma Kaul, Eddie Ryan, Connie Chick, Jeff Johnson

12. 2009 Atlas Timing Epi Trends HC Utilization XX CVD XX First Nations Kidney Disease LL Amputation Mental Health Under 20 Pregnancy JulyAugSeptOctNovDecJan 09FebMarch X Sheri Pohar WG review codes and data elements/presentation plan ADSS Data analyst run data and create initial draft chapter WG review & edit draft chapter

13. 2009 Dissemination Strategy Report – targeted for June 2009 Electronic Website Newsletter  Transition to electronic distribution (have fewer paper-copies available)

14. Atlas Table of Contents 2011  Natural History approach (in addition or in place of Traditional approach...?) Cohort of incident DM cases ’95 & ’96 Total n > 14,000 people Report baseline presence and subsequent development of comorbidities/complications ?Presenting regional variation results?  Other Potential Data Sources Regional Lab data AHW/Blue Cross Drug data (>65 years) Survey data (ABCD)